Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897036503> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W2897036503 endingPage "243" @default.
- W2897036503 startingPage "237" @default.
- W2897036503 abstract "Managing primary or even secondary glomerulonephritis remains a challenge to many nephrologists. In primary focal segmental glomerulosclerosis (FSGS) with heavy proteinuria, renin aldosterone system blockade and high dose of oral prednisolone is the mainstay of treatment. Other immunosuppressive medications like Cyclophosphamide, Cyclosporine A and Mycophenolate Mofetil (MMF) are warranted if a complete remission is not achieved. We illustrate a case of 21 year old gentleman with primary FSGS that was difficult to achieve remission despite on high dose steroid and oral Cyclophosphamide. He was also not responsive to a combination of MMF and Cyclosporine A (CSA) and even throughout the therapy he developed significant steroid and CSA toxicity. He presented to our center with severe nephrotic syndrome and acute kidney injury requiring acute haemodialysis. Despite re-challenged him again on high dose prednisolone, total of 2.4g of intravenous Cyclophosphamide, and MMF, he failed to achieve remission. He was subsequently given intravenous Rituximab 500mg/weekly for 4 doses and able to attained remission for 1 year. He relapsed again and a second course of Rituximab 500mg/weekly for 6 doses were given to attain remission. This case demonstrates the difficulty in managing refractory steroid dependent FSGS and we found that Rituximab is proven beneficial in this case to induce remission." @default.
- W2897036503 created "2018-10-26" @default.
- W2897036503 creator A5007403370 @default.
- W2897036503 creator A5013995627 @default.
- W2897036503 creator A5024721421 @default.
- W2897036503 creator A5043754307 @default.
- W2897036503 creator A5069283684 @default.
- W2897036503 creator A5071363982 @default.
- W2897036503 creator A5073666998 @default.
- W2897036503 date "2018-07-01" @default.
- W2897036503 modified "2023-09-27" @default.
- W2897036503 title "Intravenous Rituximab in Severe Refractory Primary Focal Segmental Glomerulosclerosis." @default.
- W2897036503 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30333274" @default.
- W2897036503 hasPublicationYear "2018" @default.
- W2897036503 type Work @default.
- W2897036503 sameAs 2897036503 @default.
- W2897036503 citedByCount "1" @default.
- W2897036503 countsByYear W28970365032022 @default.
- W2897036503 crossrefType "journal-article" @default.
- W2897036503 hasAuthorship W2897036503A5007403370 @default.
- W2897036503 hasAuthorship W2897036503A5013995627 @default.
- W2897036503 hasAuthorship W2897036503A5024721421 @default.
- W2897036503 hasAuthorship W2897036503A5043754307 @default.
- W2897036503 hasAuthorship W2897036503A5069283684 @default.
- W2897036503 hasAuthorship W2897036503A5071363982 @default.
- W2897036503 hasAuthorship W2897036503A5073666998 @default.
- W2897036503 hasConcept C121332964 @default.
- W2897036503 hasConcept C126322002 @default.
- W2897036503 hasConcept C126894567 @default.
- W2897036503 hasConcept C141071460 @default.
- W2897036503 hasConcept C142424586 @default.
- W2897036503 hasConcept C2776694085 @default.
- W2897036503 hasConcept C2776715498 @default.
- W2897036503 hasConcept C2776755627 @default.
- W2897036503 hasConcept C2778415529 @default.
- W2897036503 hasConcept C2778930706 @default.
- W2897036503 hasConcept C2779338263 @default.
- W2897036503 hasConcept C2779561371 @default.
- W2897036503 hasConcept C2780091579 @default.
- W2897036503 hasConcept C2780653079 @default.
- W2897036503 hasConcept C71924100 @default.
- W2897036503 hasConcept C87355193 @default.
- W2897036503 hasConcept C90924648 @default.
- W2897036503 hasConceptScore W2897036503C121332964 @default.
- W2897036503 hasConceptScore W2897036503C126322002 @default.
- W2897036503 hasConceptScore W2897036503C126894567 @default.
- W2897036503 hasConceptScore W2897036503C141071460 @default.
- W2897036503 hasConceptScore W2897036503C142424586 @default.
- W2897036503 hasConceptScore W2897036503C2776694085 @default.
- W2897036503 hasConceptScore W2897036503C2776715498 @default.
- W2897036503 hasConceptScore W2897036503C2776755627 @default.
- W2897036503 hasConceptScore W2897036503C2778415529 @default.
- W2897036503 hasConceptScore W2897036503C2778930706 @default.
- W2897036503 hasConceptScore W2897036503C2779338263 @default.
- W2897036503 hasConceptScore W2897036503C2779561371 @default.
- W2897036503 hasConceptScore W2897036503C2780091579 @default.
- W2897036503 hasConceptScore W2897036503C2780653079 @default.
- W2897036503 hasConceptScore W2897036503C71924100 @default.
- W2897036503 hasConceptScore W2897036503C87355193 @default.
- W2897036503 hasConceptScore W2897036503C90924648 @default.
- W2897036503 hasIssue "3" @default.
- W2897036503 hasLocation W28970365031 @default.
- W2897036503 hasOpenAccess W2897036503 @default.
- W2897036503 hasPrimaryLocation W28970365031 @default.
- W2897036503 hasRelatedWork W1985654865 @default.
- W2897036503 hasRelatedWork W1992764385 @default.
- W2897036503 hasRelatedWork W2097607531 @default.
- W2897036503 hasRelatedWork W2159526233 @default.
- W2897036503 hasRelatedWork W2159732018 @default.
- W2897036503 hasRelatedWork W2165789779 @default.
- W2897036503 hasRelatedWork W2426284493 @default.
- W2897036503 hasRelatedWork W2571795535 @default.
- W2897036503 hasRelatedWork W2762055363 @default.
- W2897036503 hasRelatedWork W2897036503 @default.
- W2897036503 hasVolume "50" @default.
- W2897036503 isParatext "false" @default.
- W2897036503 isRetracted "false" @default.
- W2897036503 magId "2897036503" @default.
- W2897036503 workType "article" @default.